Latest Period
Q2 2026
Security Snapshot
ENDRA Life Sciences Inc. - COM (NDRA) Institutional Ownership
CUSIP: 29273B500
13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026
Institutions Reporting
10
Shares (Excl. Options)
153,657
Price
$5.33
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- NDRA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 153,657
- Total 13F value
- $818,991
- Portfolio coverage rank
- 0%
- Share change
- +64,021
- Value change
- +$341,236
- Number of holders
- 10
- SEC-reported price per share
- $5.61
- Insider filing price
- $5.61
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NDRA - ENDRA Life Sciences Inc. - COM is tracked under CUSIP 29273B500.
- 10 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 8 to 10 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $416,807 to $818,991.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 10 institutions filings for Q2 2026.
Security key
29273B500
Latest holder period
Q2 2026
13F holders
10
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
NDRA full holder history
ENDRA Life Sciences Inc. SEC filings
ENDRA Life Sciences Inc. company facts
ENDRA Life Sciences Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29273B500:
As of 30 Jun 2026, 10 institutional investors reported holding 153,657 shares of ENDRA Life Sciences Inc. - COM (NDRA).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 153,657 | $818,991 | +$341,236 | $5.33 | 10 |
| 2026 Q1 | 89,636 | $416,807 | +$82,822 | $4.65 | 8 |
| 2025 Q4 | 71,825 | $325,366 | +$255,093 | $4.53 | 7 |
| 2025 Q3 | 13,086 | $70,401 | +$44,934 | $5.38 | 5 |
| 2025 Q2 | 4,736 | $16,623 | +$11,976 | $3.51 | 3 |
| 2025 Q1 | 1,134 | $4,649 | +$3,957 | $4.05 | 2 |
| 2024 Q4 | 112 | $701 | +$701 | $6.25 | 3 |